Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Expert Opinion on Drug Metabolism & Toxicology|August 28, 2014
Polymorphisms of the drug transporters ABCB1, ABCG2, ABCC2 and ABCC3 and their impact on drug bioavailability and clinical relevanceOliver Bruhn, Ingolf Cascorbi
European Journal of Clinical Pharmacology|May 4, 2013
Challenges in pharmacogeneticsIngolf Cascorbi, Oliver Bruhn, Anneke N Werk
Veterinary Research|September 6, 2011
Antimicrobial peptides and proteins of the horse--insights into a well-armed organismOliver Bruhn, Joachim Grötzinger, Ingolf Cascorbi, et al.
BMC Genomics|December 25, 2009
The repertoire of equine intestinal alpha-defensinsOliver Bruhn, Sven Paul, Jens Tetens, et al.
Pharmacogenomics|February 20, 2016
Length variants of the ABCB1 3'-UTR and loss of miRNA binding sites: possible consequences in regulation and pharmacotherapy resistanceOliver Bruhn, Katharina Drerup, Meike Kaehler, et al.
Pharmacogenetics and Genomics|January 14, 2012
MicroRNA profiling in K-562 cells under imatinib treatment: influence of miR-212 and miR-328 on ABCG2 expressionEleonora Turrini, Sierk Haenisch, Sandra Laechelt, et al.
Experimental Hematology & Oncology|October 1, 2020
Expression differences of miR-142-5p between treatment-naïve chronic myeloid leukemia patients responding and non-responding to imatinib therapy suggest a link to oncogenic ABL2, SRI, cKIT and MCL1 signaling pathways critical for development of therapy resistanceTheresa Klümper, Henrike Bruckmueller, Tobias Diewock, et al.
Molecular Pharmacology|May 5, 2011
Down-regulation of ATP-binding cassette C2 protein expression in HepG2 cells after rifampicin treatment is mediated by microRNA-379Sierk Haenisch, Sandra Laechelt, Henrike Bruckmueller, et al.
Plos One|June 22, 2016
OpenVigil FDA - Inspection of U.S. American Adverse Drug Events Pharmacovigilance Data and Novel Clinical ApplicationsRuwen Böhm, Leocadie von Hehn, Thomas Herdegen, et al.
Molecular Pharmacology|November 24, 2019
Alternative Polyadenylation of ABC Transporters of the C-Family (ABCC1, ABCC2, ABCC3) and Implications on Posttranscriptional Micro-RNA RegulationOliver Bruhn, Marie Lindsay, Friederike Wiebel, et al.
Pageof 2